The institutional experience of the implementing 4DCT in NSCLC radiotherapy planning
Huy Quang Dang, Cong Thanh Nguyen, Hoat Viet Pham, Linh Duc Tran, Cong Duc Nguyen, Dung Vu Manh Truong, Trang Thi Kieu Hoang, Tao Van Chau
Reports of Practical Oncology and Radiotherapy 2023, Volume 28, Number 4, pages: 445–452
ABSTRACT
Background:The study was to evaluate the effectiveness of dose distribution of four-dimensional computed tomography (4DCT) simulation.
Materials and methods: The gross tumor volume (GTV) and clinical target volume (CTV) were contoured in all 10 respiratory phases of 4DCT in 30 patients with non-small cell lung cancer (NSCLC). Both 3D and 4D treatment plans were made individually for each patient using the planning volume (PTV). The PTV3D was taken from a single CTV plus the recommended margin, and the PTV4D was taken from the 4D internal target volume, including all 10 CTVs plus the setup margins.
Results: The mean PTV was 460 ± 179 (69–820) cm3 for 3DCT and 401 ± 167 (127–854) cm3 for 4DCT (p = 0.0018). The dose distribution (DD) of organs at risk, especially the lungs, was lower for the 4DCT simulation. The V5%, V10%, and V20% of the total lung dose for 4DCT were significantly lower for the 3DCT. However, lung V30% the heart, esophagus, and spinal cord were not significantly different. In addition, the conformity index and the dose heterogeneity index of the PTV were not significantly different. The normal tissue complication probability (NTCP) of the lung and heart was significantly lower for
4DCT than for 3DCT.
Conclusions: The 4DCT simulation gives better results on the NTCP. The organs at risk, especially the lungs, receive a significantly lower DD compared with the 3DCT. The conformity index (CI), heterogeneity index (HI) and the DD to the heart, spinal cord, and esophagus were not significantly different between the two techniques.
Key words: 4DCT simulation technique; 3D-CRT; NTCP; HI; CI
More detail >>
